Aquestive Therapeutics, Inc. (AQST)
4.20
+0.21
(+5.26%)
USD |
NASDAQ |
Jun 11, 16:00
4.14
-0.06
(-1.43%)
After-Hours: 19:52
Aquestive Therapeutics Market Cap : 521.99M for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 495.90M |
| June 09, 2026 | 495.90M |
| June 08, 2026 | 485.95M |
| June 05, 2026 | 488.44M |
| June 04, 2026 | 514.54M |
| June 03, 2026 | 500.87M |
| June 02, 2026 | 488.44M |
| June 01, 2026 | 497.14M |
| May 29, 2026 | 499.62M |
| May 28, 2026 | 499.62M |
| May 27, 2026 | 501.80M |
| May 26, 2026 | 511.84M |
| May 22, 2026 | 516.85M |
| May 21, 2026 | 530.65M |
| May 20, 2026 | 523.13M |
| May 19, 2026 | 513.09M |
| May 18, 2026 | 518.74M |
| May 15, 2026 | 523.13M |
| May 14, 2026 | 593.38M |
| May 13, 2026 | 518.11M |
| May 12, 2026 | 521.87M |
| May 11, 2026 | 544.45M |
| May 08, 2026 | 536.91M |
| May 07, 2026 | 516.25M |
| May 06, 2026 | 516.25M |
| Date | Value |
|---|---|
| May 05, 2026 | 510.15M |
| May 04, 2026 | 515.03M |
| May 01, 2026 | 512.59M |
| April 30, 2026 | 500.38M |
| April 29, 2026 | 494.28M |
| April 28, 2026 | 499.16M |
| April 27, 2026 | 500.38M |
| April 24, 2026 | 497.94M |
| April 23, 2026 | 496.72M |
| April 22, 2026 | 506.49M |
| April 21, 2026 | 529.68M |
| April 20, 2026 | 517.47M |
| April 17, 2026 | 527.23M |
| April 16, 2026 | 519.91M |
| April 15, 2026 | 517.47M |
| April 14, 2026 | 506.49M |
| April 13, 2026 | 511.37M |
| April 10, 2026 | 497.94M |
| April 09, 2026 | 508.93M |
| April 08, 2026 | 510.15M |
| April 07, 2026 | 504.05M |
| April 06, 2026 | 499.16M |
| April 02, 2026 | 504.05M |
| April 01, 2026 | 504.05M |
| March 31, 2026 | 506.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 1.206B |
| Crinetics Pharmaceuticals, Inc. | 3.530B |
| Talphera, Inc. | 41.28M |
| Aytu Biopharma, Inc. | 23.61M |
| Journey Medical Corp. | 171.38M |
Market Cap Related Metrics
| PS Ratio | 9.493 |
| PEG Ratio | -2.107 |
| Price | 4.20 |
| Earnings Yield | -14.36% |
| PEGY Ratio | -2.107 |